SCHEMBL6695006

SCHEMBL6695006

COc1cccc(CNc2cccc(NCc3cccc(OC)c3)c2)c1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.68
ALDH1A1 P00352 4/20 0.67
KDM4E B2RXH2 2/20 0.67
MEN1 O00255 2/20 0.67
KMT2A Q03164 2/20 0.67
GAA P10253 1/20 0.67
HIF1A Q16665 1/20 0.65
NOS1 P29475 1/20 0.58
ABCB1 P08183 1/20 0.57
ABCG2 Q9UNQ0 1/20 0.57
CHRM2 P08172 2/20 0.57
HDAC4 P56524 1/20 0.56
MEF2D Q14814 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.54
NPC1 O15118 1/20 0.54
ALOX15 P16050 1/20 0.54
RAB9A P51151 1/20 0.54
HSD17B10 Q99714 1/20 0.54
CHRM1 P11229 1/20 0.53
CHRM3 P20309 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24097464 0.96 MAPT (0.68) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1134085 0.91 HIF1A (0.76) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL30373777 0.91 HIF1A (0.76) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL6693492 0.91 MAPT (0.69) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL25547611 0.89 MAPT (0.60) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL631899 0.89 MAPT (0.71) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL1757487 0.88 HIF1A (0.63) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL10055018 0.87 NOS1 (0.63) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL21035304 0.85 MAPT (0.64) MAPTALDH1A1KDM4EMEN1KMT2A
SCHEMBL27892973 0.85 MAOB (0.57) MAPTALDH1A1KDM4EMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups 4SC AG (DE) 2004-01-15 US disclosed
WO-2003076388-A2 BIS-ANILINE DERIVATIVES USEFUL AS POTASSIUM CHANNELS MODULATORS 4SC AG (DE) 2003-09-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040009973-A1 Phenylenediamine derivatives N-substituted with benzyl- or heteroarylmethyl- groups PAH, PNMT, OPRM1 MAPT 3951/4885ALDH1A1 458/4885KDM4E 2747/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.